A sad story - which may teach us a lesson
The Guardian had this story this morning: "Doyne was 19 when she succumbed to an extremely rare form of liver cancer whose recurrence went undiagnosed becaus...
OK this is not good
We know that nutrition matters when it comes to cancer. The other day, the BBC ran a story on a Thai dish that may cause high rates of liver cancer: http://w...
New to Care Across? Sign up to read all comments and join the conversation
Latest research available at a glance
Combination therapy against HR-positive, HER2-negative advanced breast cancer
Buparlisib, in combination with fulvestrant endocrine therapy, improved outcomes for patients with hormone (HR)-positive advanced breast cancer after treatment with everolimus plus exemestane.
Some leukemia patients may be able to safely stop their treatment
According to new research, some chronic myeloid leukemia (CML) patients may benefit from stopping their Tyrosine Kinase Inhibitor (TKI) treatments.